Northern Trust Corp Novavax Inc Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Novavax Inc stock. As of the latest transaction made, Northern Trust Corp holds 1,157,076 shares of NVAX stock, worth $15.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,157,076

Previous 1,064,760 8.67%

Holding current value

$15.4 Million

Previous $5.09 Million 187.84%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $359,109 - $1.94 Million	92,316 Added 8.67%	1,157,076 $14.6 Million
Q1 2024 May 14, 2024	BUY	$3.76 - $6.02 $234,627 - $375,654	62,401 Added 6.23%	1,064,760 $5.09 Million
Q4 2023 Feb 13, 2024	BUY	$4.8 - $7.67 $655,564 - $1.05 Million	136,576 Added 15.77%	1,002,359 $4.81 Million
Q3 2023 Nov 13, 2023	SELL	$6.81 - $9.74 $28,098 - $40,187	-4,126 Reduced 0.47%	865,783 $6.27 Million
Q2 2023 Aug 11, 2023	BUY	$6.67 - $9.52 $3.14 Million - $4.48 Million	470,277 Added 117.68%	869,909 $6.46 Million
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $151,649 - $328,573	26,328 Added 7.05%	399,632 $2.77 Million
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $194,955 - $550,980	22,004 Added 6.26%	373,304 $3.84 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $1,419 - $5,937	78 Added 0.02%	351,300 $6.39 Million
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $2.78 Million - $5.77 Million	-76,637 Reduced 17.91%	351,222 $18.1 Million
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $235,059 - $481,715	3,371 Added 0.79%	427,859 $31.5 Million
Q4 2021 Feb 08, 2022	SELL	$134.56 - $217.97 $5 Million - $8.1 Million	-37,142 Reduced 8.05%	424,488 $60.7 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $5.92 Million - $9.01 Million	33,297 Added 7.77%	461,630 $95.7 Million
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $45 Million - $95.9 Million	-372,124 Reduced 46.49%	428,333 $90.9 Million
Q1 2021 May 12, 2021	SELL	$112.98 - $319.93 $15.8 Million - $44.8 Million	-140,153 Reduced 14.9%	800,457 $145 Million
Q4 2020 Feb 11, 2021	BUY	$78.74 - $139.5 $16.7 Million - $29.6 Million	212,417 Added 29.17%	940,610 $105 Million
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $1.63 Million - $3.67 Million	20,538 Added 2.9%	728,193 $78.9 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $3.78 Million - $22.8 Million	272,488 Added 62.62%	707,655 $59 Million
Q1 2020 May 14, 2020	BUY	$3.93 - $16.0 $561,141 - $2.28 Million	142,784 Added 48.83%	435,167 $5.91 Million
Q4 2019 Feb 14, 2020	BUY	$3.69 - $5.22 $21,789 - $30,824	5,905 Added 2.06%	292,383 $1.16 Million
Q3 2019 Nov 13, 2019	BUY	$4.02 - $7.84 $199,283 - $388,652	49,573 Added 20.93%	286,478 $1.44 Million
Q2 2019 Aug 13, 2019	BUY	$4.93 - $12.2 $1.17 Million - $2.89 Million	236,905 New	236,905 $1.39 Million

Others Institutions Holding NVAX

# of Institutions

284

Shares Held

83.2M

Call Options Held

5.43M

Put Options Held

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.04B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Novavax Inc Transaction History